Now that the Supreme Court has invalidated Bilski and Warsaw's business methods patent, many are left wondering how the ruling may affect the personalized medicine industry. The article, Patent Strategy for Personalized Medicine in Light of Bilski, discusses the implications of the Bilski decision on such inventions.
Search
Fenwick & West Intellectual Property Group offers integrated advice on all aspects of the protection and exploitation of intellectual property, including patent, trademark, copyright and licensing matters.
Recent Posts
- #ALICESTORM: August 2018 Update
- Two Steps Forward, One Step Back
- Our Attention is Now Directed To: “Directed To”
- How Well-Understood is the Meaning of “Well-Understood”?
- Good Vibrations, Bad Vibrations: American Axle v. Neapco Ruling
- Thawing in the 3600s? An Updated Look at Allowance Rates Post Alice
- Seeing a Forest, Not Just Trees: Core Wireless v. LG
- Did you hear about the statistician who drowned in a lake with an average depth of two feet?
- Surviving Alice with an Appeal
- Examiner Citations of Smartgene, Cyberfone Drop After McRo Memo
Archives
FENWICK BLOGS
Follow via RSS-
Follow Us
